MAP
MDCO

Moody Aldrich Partners’s Medicines Co MDCO Stock Holding History

Moody Aldrich Partners’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-49,830
Closed -$2.49M – 169
2019
Q3 		$2.49M Sell
49,830
-508
-1% -$20.3K 0.66% 61
2019
Q2 		$1.84M Buy
+50,338
New +$1.64M 0.47% 81

Other funds holding MDCO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Moody Aldrich Partners's MDCO Position: Q4 2019 in Review

Moody Aldrich Partners sold out of Medicines Co (MDCO) in Q4 2019, closing a stake of 49,830 shares — an estimated $2.49M sold.

Moody Aldrich Partners first reported a position in MDCO in Q2 2019 and held it in 2 quarters. The position peaked at $2.49M in Q3 2019. 284 funds tracked by Wall St. Rank hold MDCO as of Q4 2019.

  • Moody Aldrich Partners reported no remaining Medicines Co position as of Q4 2019 after selling out during the quarter.
  • Moody Aldrich Partners sold 49,830 Medicines Co shares in Q4 2019, an estimated $2.49M.
  • Moody Aldrich Partners first reported a position in Medicines Co in Q2 2019 and held it in 2 quarters.
  • Moody Aldrich Partners's Medicines Co position peaked at $2.49M in Q3 2019.
  • 284 funds tracked by Wall St. Rank held Medicines Co as of Q4 2019.

Based on Moody Aldrich Partners's 13F filing for Q4 2019, filed 7 Feb 2020.